Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
Real Estate
In This Story LLY NVO HIMS The shortage of Eli Lilly’s ( LLY ) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA). Suggested Reading Miami might be in a real estate bubble, UBS says OpenAI will fall the hardest when the AI bubble bursts, analyst says Starbucks is buying up coffee farms to protect its supply How robots are playing a part in the U.S. port strike Share Share this Video Facebook Twitter Email Reddit Link view
din zilele anterioare